FDA Adverse Event
Malfunction
Summary report: N
TELIGEN
MDR report key: 1766339
·
Received July 21, 2010
Report
- Report Number
- 2124215-2010-13012
- Event Type
- Malfunction
- Date Received
- July 21, 2010
- Date of Event
- June 2, 2010
- Report Date
- June 3, 2010
- Manufacturer
- GUIDANT CRM CLONMEL IRELAND
- Product Code
- LWS
- PMA / PMN Number
- P960040
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NC
- Reporter Occupation
- MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE
Narratives
Additional Manufacturer Narrative · 1
THE PATIENT UNDERWENT DEFIBRILLATION THRESHOLD TESTING (DFT). THE DFT TESTING RETURNED IMPEDANCE MEASUREMENTS WITHIN RANGE ONCE THE COMPETITORS LEAD WAS ELECTRONICALLY DEACTIVATED. THE DFT TESTING WAS SUCCESSFUL IN A SINGLE COIL CONFIGURATION. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Description of Event or Problem · 1
BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT THIS DEVICE DETECTED HIGH, OUT OF RANGE SHOCK IMPEDANCES ON A COMPETITOR'S SUBCUTANEOUS ARRAY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | TELIGEN | IMPLANTABLE CARDIOVERTER DEFIBRILLATOR | LWS | GUIDANT CRM CLONMEL IRELAND | E110 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 63 YR | 0181| 6996SQ| 4135| E110| 0185 |